Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo. Taking two 2.5mg Mounjaro shots in one week, or doubling up in any other way, is not how tirzepatide is prescribed or licensed in the UK. Each pre-filled KwikPen is designed to deliver one weekly dose; the 2.5mg strength is a starter dose that exists to ease your body into treatment, not to be combined. If you feel the 2.5mg dose isn't doing enough, that's a clinical conversation, not something to solve by taking two pens. Mounjaro is a prescription-only medicine, and any change to your dosing schedule should be agreed with your prescriber, not adjusted at home.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the most common reason people search for this. You've been on 2.5mg for a month, the scale hasn't moved the way you expected, and you're wondering whether an extra shot would speed things along. It's a completely understandable thought, and if you've found yourself asking whether you can take two 2.5 Mounjaro shots, you're not alone in thinking it. But the 2.5mg dose isn't meant to produce noticeable weight loss on its own, it's a settling-in period. Your prescriber started you there to reduce the chance of nausea and gut discomfort that tends to hit hardest in the first few weeks of treatment.
The NHS patient information page for tirzepatide explains that treatment begins at 2.5mg for the first four weeks before your prescriber considers increasing the dose. Taking two shots of 2.5mg would expose you to double the amount of active medicine without any evidence that it improves outcomes, and with a much higher likelihood of side effects. Nausea, vomiting, diarrhoea and stomach pain are already the most commonly reported effects at the starter dose; doubling it doesn't halve your adjustment time, it compounds the problem.
If four weeks at 2.5mg feels like it hasn't moved anything, talk to your prescriber. That's what the review process is for. Our clinical team at nume hears this concern regularly, patience at this stage is genuinely part of the treatment.
Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that regulate appetite, blood-sugar response and how quickly your stomach empties. That slowing of gastric emptying is precisely why side effects cluster in the gut, and precisely why the dose escalation schedule exists: your body needs time to adapt.
Taking two 2.5mg shots in the same week, or on the same day, would effectively give you a 5mg dose without the gradual adaptation the titration schedule is designed to provide. Many people searching for guidance find themselves wondering whether you can take two 2.5mg of Mounjaro, and the honest answer is that the 5mg maintenance step exists and is well-studied, but patients reach it after a supervised four-week period at the lower dose. You can read more about what the 5mg dose involves if that's where you're hoping to get to, but getting there safely means going through the proper titration, not bypassing it.
There is also a practical point worth knowing: the pen itself is designed around weekly use. Trying to administer additional injections from the same pen isn't how the device was engineered to work, and the SmPC (the prescribing document governing Mounjaro) does not permit this approach. Your prescriber is bound by that document.
If you genuinely feel 2.5mg isn't enough (or if the side effects at that dose were actually manageable and you want to discuss moving up) the answer is a clinical review, not a second shot. Dose increases in tirzepatide are decided on a case-by-case basis, typically after at least four weeks at the current dose and with evidence that it's being tolerated well.
It's worth being specific when you speak to your prescriber: what have you noticed, what side effects (if any) have you had, how consistent have you been with once-weekly injections? That information shapes what comes next. Some patients do manage well enough to progress at the standard intervals; others need a longer period at a given dose. There's no universal right answer, which is exactly why this is a prescriber's call. If you're wondering whether an increase can ever happen faster than the standard schedule, the question about early dose increases gets into the detail.
If you're still deciding where to start and want a clearer picture of how the whole titration journey works, the Mounjaro overview sets out the full licensed dose pathway. And if cost is part of what's driving the question, for instance if you're looking into whether taking 2 lots of 2.5 Mounjaro might make a single pen stretch further, the context around Mounjaro pricing in the UK is worth reading before drawing any conclusions. Payday timing, holidays and delivery cut-offs can all create gaps between pens; if a gap is coming, your prescriber needs to know, not because you need a workaround, but because they may have clinical advice about managing a brief break.
If you have already taken two 2.5mg doses in error, contact your GP or call NHS 111. Common symptoms like nausea or stomach discomfort would be expected to be more pronounced; they are usually self-limiting, but you should not manage them without clinical input. Seek urgent help for severe or persistent abdominal pain that extends to your back, this requires immediate medical assessment regardless of when or how many doses were taken. You can also report unexpected reactions to the MHRA's Yellow Card scheme, which helps regulators monitor medicines in real-world use.
Mounjaro is a prescription medicine for a reason. A prescriber reviewing your case is the safest, fastest route to a dose that actually works for you. If you haven't yet started and want to understand whether you'd be eligible, you're welcome to check your eligibility with our prescribers, it's free, and a real clinician reads every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.